Abstract

BackgroundCritical care randomized controlled trials (RCTs) are often published in high-impact journals, whether general journals [the New England Journal of Medicine (NEJM), The Lancet, the Journal of the American Medical Association (JAMA)] or critical care journals [Intensive Care Medicine (ICM), the American Journal of Respiratory and Critical Care Medicine (AJRCCM), Critical Care Medicine (CCM)]. As rejection occurs in up to 97% of cases, it might be appropriate to assess pre-submission probability of being published. The objective of this study was to develop and internally validate a simplified score predicting whether an ongoing trial stands a chance of being published in high-impact general journals.MethodsA cohort of critical care RCTs published between 1999 and 2018 in the three highest impact medical journals (NEJM, The Lancet, JAMA) or the three highest impact critical care journals (ICM, AJRCCM, CCM) was split into two samples (derivation cohort, validation cohort) to develop and internally validate the simplified score. Primary outcome was journal of publication assessed as high-impact general journal (NEJM, The Lancet, JAMA) or critical care journal (ICM, AJRCCM, CCM).ResultsA total of 968 critical care RCTs were included in the predictive cohort and split into a derivation cohort (n = 510) and a validation cohort (n = 458). In the derivation cohort, the sample size (P value < 0.001), the number of centers involved (P value = 0.01), mortality as primary outcome (P value = 0.002) or a composite item including mortality as primary outcome (P value = 0.004), and topic [ventilation (P value < 0.001) or miscellaneous (P value < 0.001)] were independent factors predictive of publication in high-impact general journals, compared to high-impact critical care journals. The SCOTI score (Sample size, Centers, Outcome, Topic, and International score) was developed with an area under the ROC curve of 0.84 (95% Confidence Interval, 0.80–0.88) in validation by split sample.ConclusionsThe SCOTI score, developed and validated by split sample, accurately predicts the chances of a critical care RCT being published in high-impact general journals, compared to high-impact critical care journals.

Highlights

  • Critical care randomized controlled trials (RCTs) are often published in high-impact journals, whether general journals [the New England Journal of Medicine (NEJM), The Lancet, the Journal of the American Medical Association (JAMA)] or critical care journals [Intensive Care Medicine (ICM), the American Journal of Respiratory and Critical Care Medicine (AJRCCM), Critical Care Medicine (CCM)]

  • Many RCTs have been performed in this field and have often led to publications in the highest impact critical care journals, such as Intensive Care Medicine (ICM), the American Journal of Respiratory and Critical Care Medicine (AJRCCM), and Critical Care Medicine (CCM) [6,7,8]

  • We screened for relevant RCTs performed: (1) on critically ill patients, (2) that enrolled adults, and (3) were published between 1999 and 2018, (4) in the three highest impact general journals [The New England Journal of Medicine (NEJM), The Lancet and the Journal of the American Medical Association (JAMA)] or the three highest impact critical care journals [Intensive Care Medicine (ICM), American Journal of Respiratory and Critical Care Medicine (AJRCCM) and Critical Care Medicine (CCM)]

Read more

Summary

Introduction

Critical care randomized controlled trials (RCTs) are often published in high-impact journals, whether general journals [the New England Journal of Medicine (NEJM), The Lancet, the Journal of the American Medical Association (JAMA)] or critical care journals [Intensive Care Medicine (ICM), the American Journal of Respiratory and Critical Care Medicine (AJRCCM), Critical Care Medicine (CCM)]. Pensier et al Annals of Intensive Care (2021) 11:165 of evidence for evaluating new and existing interventions in medicine [2], as long as they are appropriately designed, conducted, and reported [3, 4] They have been further promoted by the development of online databases, reviews, meta-analyses, and education of clinicians and students [5]. Landmark trials have changed the management of critically ill patients [9,10,11,12] Many of those studies have been published in the highest impact general journals: The New England Journal of Medicine (NEJM), The Lancet, and the Journal of the American Medical Association (JAMA)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call